首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men
【2h】

Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men

机译:PHYSTA冻干杜仲提取物用于改善男性生活质量和性健康的随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eurycoma longifolia is reputed as an aphrodisiac and remedy for decreased male libido. A randomized, double-blind, placebo controlled, parallel group study was carried out to investigate the clinical evidence of E. longifolia in men. The 12-week study in 109 men between 30 and 55 years of age consisted of either treatment of 300 mg of water extract of E. longifolia (Physta) or placebo. Primary endpoints were the Quality of Life investigated by SF-36 questionnaire and Sexual Well-Being investigated by International Index of Erectile Function (IIEF) and Sexual Health Questionnaires (SHQ); Seminal Fluid Analysis (SFA), fat mass and safety profiles. Repeated measures ANOVA analysis was used to compare changes in the endpoints. The E. longifolia (EL) group significantly improved in the domain Physical Functioning of SF-36, from baseline to week 12 compared to placebo (P = 0.006) and in between group at week 12 (P = 0.028). The EL group showed higher scores in the overall Erectile Function domain in IIEF (P < 0.001), sexual libido (14% by week 12), SFA- with sperm motility at 44.4%, and semen volume at 18.2% at the end of treatment. Subjects with BMI ≥ 25 kg/m2 significantly improved in fat mass lost (P = 0.008). All safety parameters were comparable to placebo.
机译:长叶杜仲被认为是一种壮阳药,可以缓解男性性欲。进行了一项随机,双盲,安慰剂对照,平行组研究,以调查男性长叶大肠杆菌的临床证据。为期109天,年龄在30至55岁之间的109名男性患者进行了为期12周的研究,其中包括300 mg的E. longifolia(Physta)水提取物或安慰剂的治疗。主要终点是通过SF-36问卷调查的生活质量和通过国际勃起功能指数(IIEF)和性健康问卷(SHQ)调查的性健康;精液分析(SFA),脂肪量和安全性概况。重复测量ANOVA分析用于比较端点的变化。与安慰剂相比,从基线到第12周,长叶大肠杆菌(EL)组在SF-36的物理功能方面有显着改善(P = 0.006),而在第12周组之间(P = 0.028)。 EL组在IIEF(P <0.001),性欲(12周时为14%),SFA-精子运动率为44.4%,精液量为18.2%的总体勃起功能域中得分较高。 BMI≥25 kg / m 2 的受试者的脂肪量损失明显改善(P = 0.008)。所有安全参数均与安慰剂相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号